JPWO2023057769A5 - - Google Patents
Info
- Publication number
- JPWO2023057769A5 JPWO2023057769A5 JP2024521255A JP2024521255A JPWO2023057769A5 JP WO2023057769 A5 JPWO2023057769 A5 JP WO2023057769A5 JP 2024521255 A JP2024521255 A JP 2024521255A JP 2024521255 A JP2024521255 A JP 2024521255A JP WO2023057769 A5 JPWO2023057769 A5 JP WO2023057769A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- vector
- amino acid
- nucleic acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2114318.5A GB202114318D0 (en) | 2021-10-06 | 2021-10-06 | Coronavirus Vaccines |
| GB2114318.5 | 2021-10-06 | ||
| GB2214126.1 | 2022-09-27 | ||
| GBGB2214126.1A GB202214126D0 (en) | 2022-09-27 | 2022-09-27 | Coronavirus vaccines |
| PCT/GB2022/052537 WO2023057769A1 (en) | 2021-10-06 | 2022-10-06 | Coronavirus vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024539609A JP2024539609A (ja) | 2024-10-29 |
| JP2024539609A5 JP2024539609A5 (https=) | 2025-10-15 |
| JPWO2023057769A5 true JPWO2023057769A5 (https=) | 2025-10-15 |
Family
ID=83692901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024521255A Pending JP2024539609A (ja) | 2021-10-06 | 2022-10-06 | コロナウイルスワクチン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250312437A1 (https=) |
| EP (1) | EP4412645A1 (https=) |
| JP (1) | JP2024539609A (https=) |
| CN (1) | CN119013040A (https=) |
| AU (1) | AU2022358982A1 (https=) |
| CA (1) | CA3234656A1 (https=) |
| WO (1) | WO2023057769A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4687969A1 (en) * | 2023-04-05 | 2026-02-11 | DIOSynVax Ltd | Coronavirus vaccines inducing broad immunity against variants |
| WO2025083402A1 (en) * | 2023-10-16 | 2025-04-24 | Diosynvax Ltd | Coronavirus vaccines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201729835A (zh) | 2015-10-22 | 2017-09-01 | 現代公司 | 呼吸道病毒疫苗 |
| MX2022009460A (es) * | 2020-02-04 | 2022-12-16 | Curevac Ag | Vacuna contra el coronavirus. |
| WO2021160346A1 (en) * | 2020-02-13 | 2021-08-19 | Institut Pasteur | Nucleic acid vaccine against the sars-cov-2 coronavirus |
-
2022
- 2022-10-06 EP EP22790007.3A patent/EP4412645A1/en active Pending
- 2022-10-06 US US18/699,034 patent/US20250312437A1/en active Pending
- 2022-10-06 AU AU2022358982A patent/AU2022358982A1/en active Pending
- 2022-10-06 JP JP2024521255A patent/JP2024539609A/ja active Pending
- 2022-10-06 CN CN202280081276.XA patent/CN119013040A/zh active Pending
- 2022-10-06 WO PCT/GB2022/052537 patent/WO2023057769A1/en not_active Ceased
- 2022-10-06 CA CA3234656A patent/CA3234656A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3294329B1 (en) | Novel baculovirus vectors and methods of use | |
| US9630996B2 (en) | Attenuated recombinant vesicular stomatitis viruses comprising modified mutant matrix proteins | |
| JP2010099084A (ja) | Ｈｉｖ調節／アクセサリータンパク質の融合タンパク質 | |
| JP2025184979A5 (https=) | ||
| US20240123053A1 (en) | Coronavirus vaccine through nasal immunization | |
| US9943593B2 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| US10556929B2 (en) | Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infection | |
| US20110129498A1 (en) | Vaccine for the prevention and therapy of hcv infections | |
| US20210220464A1 (en) | Vaccine Composition for Preventing or Treating Diseases Caused by Severe Fever with Thrombocytopenia Syndrome (SFTS) Viral Infection | |
| NZ514619A (en) | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV | |
| Khan et al. | Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein | |
| CN120475991A (zh) | 鼻病毒mRNA疫苗 | |
| WO2023160654A1 (zh) | 一种可诱导广谱中和活性重组多组分新冠病毒三聚体蛋白疫苗的制备及应用 | |
| US20250228934A1 (en) | Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the same | |
| JPWO2023057769A5 (https=) | ||
| US20230192777A1 (en) | Epitopic vaccine for african swine fever virus | |
| US20250302943A1 (en) | Re-focusing protein booster immunization compositions and methods of use thereof | |
| JPWO2023150638A5 (https=) | ||
| JPWO2021198701A5 (https=) | ||
| KR20240125000A (ko) | 백신 조성물 및 이의 용도 | |
| CN118678968A (zh) | 疫苗组合物及其用途 | |
| CN119978138A (zh) | 包含冠状病毒的保守重组蛋白片段的疫苗组合物及其应用 | |
| Rechts | Patent Report | |
| JPWO2021247567A5 (https=) |